近年来,基因检测标准发生了重大变化。英国妇科癌症协会和英国妇科病理学家协会(BGCS/BAGP)重新组建了一个多学科专家共识小组,以最新的卵巢癌患者生殖系和肿瘤检测标准更新以前的指南。第一次,BGCS/BAGP指南组在最初的共识小组会议上纳入了一名患者顾问.我们已经使用了以患者为中心的小组来告知与反射肿瘤测试相关的讨论,这是本更新指南中的一个关键变化。本报告总结了我们的共识小组审议和审核标准的建议,以支持常规临床环境中的持续质量改进。
Standard of care genetic testing has undergone significant changes in recent years. The British Gynecological Cancer Society and the British Association of Gynecological Pathologists (BGCS/BAGP) has re-assembled a multidisciplinary expert
consensus group to update the previous guidance with the latest standard of care for germline and tumor testing in patients with ovarian cancer. For the first time, the BGCS/BAGP
guideline group has incorporated a patient advisor at the initial
consensus group meeting. We have used patient focused groups to inform discussions related to reflex tumor testing - a key change in this updated guidance. This report summarizes recommendations from our
consensus group deliberations and audit standards to support continual quality improvement in routine clinical settings.